PPARGC1A and Huntington disease: As mentioned above, PGC-1α activity is also decreased in muscle from HD patients and N171-82Q mice [35] and given the pathology that we have described in R6/2 and HdhQ150/Q150 liver, an investigation of the UCPs in liver is warranted.